Oncology is the hot bed of drug development using big data sets. Here we will learn more from the latest studies in the space with developments of new diagnostic technologies and understanding tumour driving genes and drug targets we can develop new cures.
Martin Preusse, Chief Executive Officer, Kaiser & Preusse
Pandu Raharja-Liu, Co-Founder and Chief Technology Officer, Panakeia Technologies Limited
Derek Burke, UK&I Regional Sales Manager, WekaIO
Siobhan Southam, Digital Experimental Cancer Medicine Team - Strategic Engagement Leader, AstraZeneca
Letizia Gionfrida, Chief Executive Officer, Arthronica
Miron Tokarski, Chief Executive Officer, Genomtec
Stephan Cichos, Principal Data Manager, Bayer